ブックタイトル血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

概要

血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

129. Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution.Clin Infect Dis 2003; 36:1539?44.130. Elhassan NO, Stevens TP, Gigliotti F, Hardy DJ, Cole CA, Sinkin RA. Vancomycin usage in central venouscatheters in a neonatal intensive care unit. Pediatr Infect Dis J 2004; 23:201?6.131. McIntyre CW, Hulme LJ, Taal M, Fluck RJ. Locking of tunneled hemodialysis catheters with gentamicin andheparin. Kidney Int 2004; 66:801?5.132. Betjes MG, van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidinecontaininglock solution. Nephrol Dial Transplant 2004; 19:1546?1.133. Weijmer MC, van den Dorpel MA, Van de Ven PJ, et al. Randomized, clinical trial comparison of trisodiumcitrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 2005;16:2769?77.134. Bleyer AJ, Mason L, Russell G, Raad II, Sherertz RJ. A randomized, controlled trial of a new vascularcatheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control HospEpidemiol 2005; 26:520?4.135. Kim SH, Song KI, Chang JW, et al. Prevention of uncuffed hemodialysis catheter-related bacteremia usingan antibiotic lock technique: a prospective, randomized clinical trial. Kidney Int 2006; 69:161?4.136. Al-Hwiesh AK, Abdul-Rahman IS. Successful prevention of tunneled, central catheter infection by antibioticlock therapy using vancomycin and gentamycin. Saudi J Kidney Dis Transpl 2007; 18:239?47.137. Nori US, Manoharan A, Yee J, Besarab A. Comparison of low-dose gentamicin with minocycline as catheterlock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis 2006; 48:596?605.138. Saxena AK, Panhotra BR, Sundaram DS, et al. Tunneled catheters’outcome optimization among diabeticson dialysis through antibiotic-lock placement. Kidney Int 2006; 70:1629?35.139. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in central venous and pulmonaryartery catheters: a meta-analysis of randomized controlled trials. Chest 1998; 113:165?71.140. Tager IB, Ginsberg MB, Ellis SE, et al. An epidemiologic study of the risks associated with peripheralintravenous catheters. Am J Epidemiol 1983; 118:839?51.141. Lai KK. Safety of prolonging peripheral cannula and i.v. tubing use from 72 hours to 96 hours. Am J InfectControl 1998; 26:66?70.142. Van Donk P, Rickard CM, McGrail MR, Doolan G. Routine replacement versus clinical monitoring ofperipheral intravenous catheters in a regional hospital in the home program: a randomized controlled trial.Infect Control Hosp Epidemiol 2009; 30:915?7.143. Webster J, Clarke S, Paterson D, et al. Routine care of peripheral intravenous catheters versus clinicallyindicated replacement: randomised controlled trial. BMJ 2008; 337:a339.144. Webster J, Osborne S, Rickard C, Hall J. Clinically-indicated replacement versus routine replacement ofperipheral venous catheters. Cochrane Database Syst Rev 2010; 3:CD007798.145. Boo NY, Wong NC, Zulkifli SS, Lye MS. Risk factors associated with umbilical vascular catheter-associatedthrombosis in newborn infants. J Paediatr Child Health 1999; 35:460?5.146. Garland JS, Buck RK, Maloney P, et al. Comparison of 10% povidone-iodine and 0.5% chlorhexidinegluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial.Pediatr Infect Dis J 1995; 14:510?6.147. Krauss AN, Albert RF, Kannan MM. Contamination of umbilical catheters in the newborn infant. J Pediatr1970; 77:965?9.148. Landers S, Moise AA, Fraley JK, Smith EO, Baker CJ. Factors associated with umbilical catheter-relatedsepsis in neonates. Am J Dis Child 1991; 145:675?80.56